
jetcityimage
Rhythm Pharmaceuticals (RYTM) rose 5.4% amid a report that Eli Lilly (LLY) is evaluating two possible takeover targets in the obesity market, including Rhythm and Viking Therapeutics (VKTX).
After the WSJ reported that AstraZeneca (AZN) made a bid for